Artwork

Content provided by Joel Nowak Cancer ABCs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joel Nowak Cancer ABCs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

42:19
 
Share
 

Manage episode 242232907 series 2381686
Content provided by Joel Nowak Cancer ABCs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joel Nowak Cancer ABCs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Written Transcript at:
https://www.cancerabcs.org/transcript-provengesurvivaladvantage
Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American background.
Along the way, they also talk about what is immunotherapy, how it works, how Provenge is actually administered, its side effects and who should get the treatment and where in their treatment schedule would it be best to get the treatment.
Support the show

  continue reading

24 episodes

Artwork
iconShare
 
Manage episode 242232907 series 2381686
Content provided by Joel Nowak Cancer ABCs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joel Nowak Cancer ABCs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Written Transcript at:
https://www.cancerabcs.org/transcript-provengesurvivaladvantage
Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American background.
Along the way, they also talk about what is immunotherapy, how it works, how Provenge is actually administered, its side effects and who should get the treatment and where in their treatment schedule would it be best to get the treatment.
Support the show

  continue reading

24 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide